Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hallal David
Relationship:   Director
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   2,978,651    

Indirect Shares

   17,647,006      
Direct Value   $38,642,476    

Indirect Value

   $34,321,195      
Total Shares   20,625,657      
Total Value   $72,963,670      


Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,429,374 Allovir Inc $1,672,056 Seer, Inc. $0 Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,429,374 Allovir Inc $1,672,056 Seer, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -113.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN CEO, Director 2016-08-08 189,266 2014-12-18 113,122    Premium*  
            Scholar Rock Holding Corp SRRK Director 2019-09-18 290,595 2019-09-18 0    Premium*  
            Allovir Inc ALVR 2024-06-06 2,143,662 2024-06-06 17,533,884    Premium*  
            Seer, Inc. SEER 2024-06-12 355,128 0    Premium*  
            Iteos Therapeutics, Inc. ITOS Director 2022-06-09 0 2021-12-20 0    Premium*  
* Premium Members only  

Records found :    129         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ITOS Iteos Therapeutics, Inc. Director   –       •      –    2022-06-09 4 OE $4.23 $4,953 D/D 1,171 1,171 0 -
ALVR Allovir Inc Director   –       •       •   2022-07-28 4 A $4.61 $15,000,000 I/I 3,253,796 16,674,766 0 -
ALVR Allovir Inc Director   –       •       •   2022-07-21 4 AS $5.33 $22,528 D/D (4,227) 2,073,662 0 %
ALVR Allovir Inc Director   –       •       •   2022-04-21 4 AS $5.87 $24,812 D/D (4,227) 2,143,614 0 %
ALVR Allovir Inc Director   –       •       •   2022-09-29 4 S $7.35 $2,940,920 I/I (400,000) 720,965 0 %
ALVR Allovir Inc Director   –       •       •   2022-03-11 4 AS $7.37 $186,068 D/D (25,244) 2,147,841 0 %
ALVR Allovir Inc Director   –       •       •   2022-03-10 4 AS $7.55 $305,781 D/D (40,481) 2,173,085 0 %
ALVR Allovir Inc Director   –       •       •   2022-01-24 4 S $8.01 $136,889 D/D (17,100) 2,213,566 0 %
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2011-08-05 4 OE $8.16 $40,800 D/D 5,000 34,735 0 -
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2011-08-08 4 OE $8.16 $40,800 D/D 5,000 39,735 0 -
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2011-12-30 4 OE $8.16 $24,480 D/D 3,000 42,735 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-10-24 4 OE $8.16 $85,680 D/D 10,500 72,475 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-10-24 4 OE $8.16 $85,680 D/D 10,500 72,475 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-06-05 4 OE $8.16 $204,281 D/D 15,008 89,654 0 -
ALVR Allovir Inc Director   –       •       •   2022-10-19 4 S $8.45 $5,070,000 I/I (600,000) 138,153 0 %
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2011-07-28 4 OE $10.29 $379,413 D/D 36,872 66,607 0 -
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2011-11-28 4 OE $11.92 $238,400 D/D 20,000 59,735 0 -
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2012-02-23 4 OE $11.92 $476,800 D/D 40,000 93,210 0 -
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2012-06-15 4 OE $11.92 $170,551 D/D 14,308 77,518 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2009-12-11 4 OE $16.32 $163,200 D/D 10,000 20,243 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-03-02 4 OE $16.32 $163,200 D/D 10,000 17,770 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-11-04 4 OE $16.32 $326,400 D/D 20,000 23,770 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-12-14 4 OE $16.32 $81,600 D/D 5,000 8,770 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-12-15 4 OE $16.32 $222,213 D/D 13,616 22,386 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-12-27 4 OE $16.32 $40,800 D/D 2,500 11,270 0 -
  129  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us